methylphenidate

(redirected from Ritalin SR)
Also found in: Thesaurus, Medical.

meth·yl·phen·i·date

 (mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

[methyl + phen(yl) + (piper)id(ine) + (acet)ate.]

methylphenidate

(ˌmɛθɪlˈfɛnɪˌdeɪt; ˌmɛθɪlˈfiːnɪˌdeɪt)
n
(Pharmacology) a drug that stimulates the central nervous system and is used, in the form of its hydrochloride, to treat narcolepsy as well as attention deficit disorder

meth•yl•phen•i•date

(ˌmɛθ əlˈfɛn ɪˌdeɪt, -ˈfi nɪ-)

n.
a central nervous system stimulant, C14H19NO2, used in the control of hyperkinetic syndromes and narcolepsy.
[1955–60; methyl + phen- + -ide + -ate2]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.methylphenidate - central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in childrenmethylphenidate - central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in children
excitant, stimulant drug, stimulant - a drug that temporarily quickens some vital process
Translations

methylphenidate

n metilfenidato
References in periodicals archive ?
5, 15, 20, 30 mg); methylphenidate (Concerta) (18, 27, 36, 54 mg); and three formulations of methylphenidate (Ritalin), including Ritalin SR and Ritalin LA.
The ruling applies to 15 products: Adderall tablets, Adderall XR extended-release capsules, Concerta extended-release tablets, Daytrana transdermal system, Desoxyn tablets, Dexedrine Spansule capsules and tablets, Focalin tablets, Focalin XR extended-release capsules, Metadate CD extended-release capsules, Methylin oral solution, Methylin chewable tablets, Ritalin tablets, Ritalin SR sustained-release tablets, Ritalin LA extended-release capsules, and Strattera capsules.
Celgene licensed the worldwide rights (excluding Canada) to FOCALIN and FOCALIN XR to Novartis Pharma AG in exchange for milestone payments and royalties on FOCALIN and the entire Ritalin family of drugs including Ritalin, Ritalin LA, Ritalin SR and ultimately FOCALIN XR.
A less-effective, extended-release formulation is marketed as Ritalin SR.
based BR Pharma Limited, which first gained recognition for obtaining regulatory permission to import Ritalin SR into the U.